Compound class:
Synthetic organic
Comment: Compound 47 is a selective prostaglandin E receptor 4 (EP4 receptor) antagonist [1], that was designed to counter the immunosuppressive effect of EP4/PGE2 signalling in the tumour microenvironment.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
In the mouse CT26 colon carcinoma model compound 47 demonstrated anti-tumour activity as a monotherapy, and enhanced the anti-tumour immune response when combined with an anti-PD-1 immune checkpoint antibody [1]. The in vitro IC50 of compound 47 at the EP1, EP2 and EP3 receptors was determined to be >10 μM. |
Selectivity at GPCRs | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|